FL CARES: Cancer Drug Property Dataset

Brand Name:
Code(s): X396
Approved:
Kinase Class: RY
Inhibitor Type: ?
Literature (PubMed): <a href="https://pubchem.ncbi.nlm.nih.gov/compound/#section=Literature" target="_blank"> 0
Target(s): ALK receptor tyrosine kinase
Disease(s): non-small-cell lung carcinoma

Ensartinib US FDA Label

Compound: 6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-[(3R,5S)-3,5-dimethylpiperazine-1-carbonyl]phenyl]pyridazine-3-carboxamide
Description: NA

International Nonproprietary Name: Ensartinib [INN] (Source: PubChem)

KEGG Compound ID: C13627 (Source: PubChem)

KEGG Drug ID: D11346 (Source: PubChem)

USFDA Precision ID: UNII-SMA5ZS5B22 (Source: PubChem)

US Adopted Name: ENSARTINIB [USAN] (Source: PubChem)

Sources: PubChem (5)